Author's reply: Maternal hypertension and infant growth  by Kiy, Alice Maria & Suppo de Souza Rugolo, Ligia Maria
R604  LETTERS  TO  THE  EDITO
effect of maternal hypertension. J Pediatr (Rio J). 2015;91:
256--62.
2. American College of Obstetricians and Gynecologists. Task Force
on Hypertension in Pregnancy. Hypertension in pregnancy. Report
of the American College of Obstetricians and Gynecologists’
Task Force on Hypertension in Pregnancy. Obstet Gynecol.
2013;122:1122--31.
3. Greenwood C, Yudkin P, Sellers S, Impey L, Doyle P. Why is
there a modifying effect of gestational age on risk factors
for cerebral palsy? Arch Dis Child Fetal Neonatal Ed. 2005;90:
F141--6.
Tanara  Vogel  Pinheiro,  Marcelo  Zubaran  Goldani,
Juliana  Rombaldi  Bernardi ∗
Department  of  Pediatrics,  Faculty  of  Medicine,  Hospital
de  Clínicas  de  Porto  Alegre,  Universidade  Federal  do  Rio
Grande  do  Sul,  Porto  Alegre,  RS,  Brazil
∗Corresponding  author.
E-mail:  juliana.bernardi@yahoo.com.br  (J.R.  Bernardi).
http://dx.doi.org/10.1016/j.jped.2015.07.005y,
t
e
o
i-
e
y:
al
r-
d
-
in
ts
n
%
e
o
e
s
e
al
is
f
r-
e
o
i-
h
e
s
e
ic
le
f
t
s.
s-
h
k
ly
h
i-
ic
t
y
e
in
r
t,
e
ts
ct
s,
tAuthor’s reply: Maternal
hypertension and infant
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Resposta do autor: Hipertensão materna e
crescimento infantil
We  appreciate  the  comments  and  questions  about  our  stud
which  demonstrates  the  careful  and  correct  assessment  tha
focused  on  one  aspect  of  concern  in  cohort  studies:  th
possibility  of  selection  bias.1
We  will  use  this  opportunity  of  scientiﬁc  discussion  t
clarify  some  methodological  aspects  of  the  study  and  its  lim
tations,  ensuring  its  external  validity  and  helping  to  increas
knowledge  on  this  topic,  still  scarcely  studied  in  our  countr
low  birth-weight  preterm  growth  --  the  effect  of  matern
hypertension.
The  ﬁrst  aspect  to  be  discussed  refers  to  maternal  hype
tension  classiﬁcation,  which  in  our  study  was  performe
using  the  criteria  of  the  National  High  Blood  Pressure  Edu
cation  Program  Working  Group  on  High  Blood  Pressure  
Pregnancy.2 As  shown  in  the  ﬁrst  paragraph  of  the  resul
section,  preeclampsia  was  the  predominant  manifestatio
in  the  group  of  hypertensive  women,  corresponding  to  80
(n  =  63),  which  is  classically  described  in  the  literature.3 Th
remaining  20%  of  this  group  had  gestational  hypertension.  N
pregnant  woman  had  chronic  hypertension.
The  second  aspect  is  the  subject  of  much  discussion  in  th
literature:  what  would  be  the  ideal  control  group  in  studie
on  prognosis  of  preterm  infants?
In  development  studies,  it  is  important  to  assess  th
damage  in  premature  infants  in  relation  to  the  gener
population.4 In  relation  to  growth,  this  comparison  
obtained  by  the  analysis  of  the  Z-scores  of  anthropometric
measurements.
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nOur  objective  was  to  analyze  the  growth  pattern  o
low  birth  weight  preterm  infants  and  the  effect  of  mate
nal  hypertension,  using  a  cohort  study  design.  Thus,  th
groups  were  formed  based  on  the  exposure  or  not  t
maternal  hypertensive  syndrome,  excluding  cases  of  mult
ple  pregnancies,  infection/congenital  malformations,  whic
are  classic  factors  associated  with  growth  alterations.  Th
neonatal  characteristics  were  similar  between  groups,  a
well  as  the  post-natal  factors  that  are  known  to  inﬂuenc
growth,  such  as  morbidity  and  dietary  patterns.  Logist
regression  models  were  constructed  to  control  for  possib
confounding  factors.
Although  the  selection  of  a  control  group  consisting  o
preterm  infants  may  limit  result  interpretation,  we  do  no
consider  that  they  should  be  attributed  to  selection  bia
The  data  obtained  allowed  us  to  answer  the  study  que
tion  on  the  effect  of  maternal  hypertension  on  the  growt
of  preterm  low  birth-weight  infants:  there  were  no  ris
or  protective  effects.  Also,  two  important  and  potential
avoidable  risk  factors  were  highlighted:  adequacy  of  birt
weight  and  growth  in  the  ﬁrst  year  of  life,  which  are  clin
cally  relevant  aspects  that  contribute  to  guide  the  obstetr
and  pediatric  conduct  in  daily  practice.
Regarding  the  third  question,  the  authors  consider  tha
there  is  a  low  possibility  of  selection  bias,  as  the  stud
sample  size  consisted  of  a  population  treated  at  th
Brazilian  Uniﬁed  Health  System,  quite  homogeneous  
socio-demographic  characteristics,  which  did  not  diffe
between  the  two  assessed  groups.  Smoking  was  infrequen
observed  in  10%  of  hypertensive  and  20%  of  normotensiv
women  (p  =  0.103).  It  is  necessary  to  highlight  two  aspec
of  methodological  rigor  in  our  study:  control  of  the  effe
of  time  on  the  evolution  of  anthropometric  measurement
and  postnatal  nutrition  assessment,  which  is  an  importan
growth  modulating  factor  in  the  ﬁrst  years  of  life.5
Finally,  we  expect  that  the  aspects  discussed  herein  ca
contribute  to  improve  the  interpretation  of  our  study  and
encourage  new  studies  to  investigate  other  factors  that  can
inﬂuence  growth  in  low  birth  weight  preterm  infants.
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